Gold nanoparticles enlighten the future of cancer theranostics

Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of nanomedicine Ročník 12; s. 6131 - 6152
Hlavní autoři:	Guo, Jianfeng, Rahme, Kamil, He, Yan, Li, Lin-Lin, Holmes, Justin, O'Driscoll, Caitriona
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New Zealand Dove Medical Press Limited 01.01.2017 Taylor & Francis Ltd Dove Medical Press
Témata:	Acids Biomedical materials cancer bioimaging Cancer diagnosis cancer photothermal and photodynamic therapy Cancer therapies Drug delivery systems Gold Gold - chemistry Humans Metal Nanoparticles - administration & dosage Metal Nanoparticles - chemistry Multifunctional gold nanoparticles Nanomaterials Nanoparticles Neoplasms - diagnosis Neoplasms - therapy Particle size Photochemotherapy Photochemotherapy - methods Photodynamic therapy Phototherapy - methods Polyethylene glycol Quantum dots Review Seeds Silver Surface Plasmon Resonance Surfactants Theranostic Nanomedicine - methods University colleges Ireland China cancer bioimaging multifunctional gold nanoparticles cancer photothermal and photodynamic therapy
ISSN:	1178-2013, 1176-9114, 1178-2013
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed.
AbstractList	Jianfeng Guo,1 Kamil Rahme,2-4 Yan He,1 Lin-Lin Li,5 Justin D Holmes,3,4 Caitriona M O'Driscoll6 1School of Pharmaceutical Sciences, Jilin University, Changchun, China; 2Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh, Lebanon; 3Department of Chemistry, Tyndall National Institute, University College Cork, Cork, 4AMBER@CRANN, Trinity College Dublin, Dublin, Ireland; 5The First Hospital of Jilin University, Changchun, China; 6Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland Abstract: Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bioimaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant todiagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed. Keywords: multifunctional gold nanoparticles, cancer bioimaging, cancer photothermal and photodynamic therapy Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed. Keywords: multifunctional gold nanoparticles, cancer bioimaging, cancer photothermal and photodynamic therapy Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bioimaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed “theranostics,” multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed. Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed.Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed. Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to revolutionize cancer diagnosis and treatment. Gold nanoparticles (AuNPs) are now being widely utilized in bio-imaging and phototherapy due to their tunable and highly sensitive optical and electronic properties (the surface plasmon resonance). As a new concept, termed "theranostics," multifunctional AuNPs may contain diagnostic and therapeutic functions that can be integrated into one system, thereby simultaneously facilitating diagnosis and therapy and monitoring therapeutic responses. In this review, the important properties of AuNPs relevant to diagnostic and phototherapeutic applications such as structure, shape, optics, and surface chemistry are described. Barriers for translational development of theranostic AuNPs and recent advances in the application of AuNPs for cancer diagnosis, photothermal, and photodynamic therapy are discussed.
Audience	Academic
Author	Holmes, Justin He, Yan Li, Lin-Lin O'Driscoll, Caitriona Guo, Jianfeng Rahme, Kamil
AuthorAffiliation	2 Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh, Lebanon 5 The First Hospital of Jilin University, Changchun, China 4 AMBER@CRANN, Trinity College Dublin, Dublin, Ireland 6 Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland 1 School of Pharmaceutical Sciences, Jilin University, Changchun, China 3 Department of Chemistry, Tyndall National Institute, University College Cork, Cork
AuthorAffiliation_xml	– name: 4 AMBER@CRANN, Trinity College Dublin, Dublin, Ireland – name: 5 The First Hospital of Jilin University, Changchun, China – name: 1 School of Pharmaceutical Sciences, Jilin University, Changchun, China – name: 6 Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland – name: 3 Department of Chemistry, Tyndall National Institute, University College Cork, Cork – name: 2 Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh, Lebanon
Author_xml	– sequence: 1 givenname: Jianfeng surname: Guo fullname: Guo, Jianfeng – sequence: 2 givenname: Kamil surname: Rahme fullname: Rahme, Kamil – sequence: 3 givenname: Yan surname: He fullname: He, Yan – sequence: 4 givenname: Lin-Lin surname: Li fullname: Li, Lin-Lin – sequence: 5 givenname: Justin surname: Holmes fullname: Holmes, Justin – sequence: 6 givenname: Caitriona surname: O'Driscoll fullname: O'Driscoll, Caitriona
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28883725$$D View this record in MEDLINE/PubMed
BookMark	eNptkktvEzEUhS1URB-wYo9GYoOEEnzt8WM2laoKSlAFC2Bt-TWJo4kd7JlK_HsckkJTVV7YOv7usY99z9FJTNEj9BrwnEArPiy-fJ1_hxYLQZ6hMwAhZwQDPXmwPkXnpawxZkLy7gU6JVJKKgg7Q5c3aXBN1DFtdR6DHXxpfBzCcjX62Iwr3_TTOGXfpL6xOlqfd2KufKl0eYme93oo_tVhvkA_P338cf15dvvtZnF9dTuzHMtxRmWPdb0iFsZojjnWnoME40nHnRDGcefAm87iHliLTWutMEIz4oxkvHP0Ai32vi7ptdrmsNH5t0o6qL9Cykt1uL6SrQApgGorSAudlRqcN77KGLQQrHpd7r22k9l4Z30csx6OTI93YlipZbpTjImW87YavDsY5PRr8mVUm1CsHwYdfZqKgo4KBlK2UNG3j9B1mnKsT6UIoR0XhNLuP7XUNUCIfarn2p2pumKUUEwJ0ErNn6DqcH4TbO2JPlT9qODNw6D_Et7_fgVgD9icSsm-VzaMegxplzsMCrDadZiqHaYOHVZr3j-qubd9iv4D2L7OXg
CitedBy_id	crossref_primary_10_1007_s12272_020_01206_5 crossref_primary_10_1088_1402_4896_acc701 crossref_primary_10_1080_17435390_2019_1621398 crossref_primary_10_1097_JCE_0000000000000354 crossref_primary_10_1021_acsnano_5c04463 crossref_primary_10_3390_catal12020167 crossref_primary_10_1002_smtd_201800365 crossref_primary_10_3389_fbioe_2019_00320 crossref_primary_10_1155_2020_5616379 crossref_primary_10_1016_j_pdpdt_2022_102979 crossref_primary_10_1021_acsami_5c05524 crossref_primary_10_1080_00222348_2024_2374651 crossref_primary_10_2217_nnm_2018_0204 crossref_primary_10_1016_j_nano_2025_102821 crossref_primary_10_2217_nnm_2023_0223 crossref_primary_10_1093_jnci_djy003 crossref_primary_10_1134_S1063783421020190 crossref_primary_10_1186_s12645_025_00314_5 crossref_primary_10_1080_17435390_2020_1808107 crossref_primary_10_26453_otjhs_753846 crossref_primary_10_1186_s12935_024_03610_z crossref_primary_10_7759_cureus_30096 crossref_primary_10_1007_s12011_020_02353_y crossref_primary_10_1002_adfm_202104199 crossref_primary_10_1016_j_jconrel_2020_12_015 crossref_primary_10_1016_j_tiv_2020_105046 crossref_primary_10_3389_fimmu_2021_758410 crossref_primary_10_3390_pharmaceutics13122131 crossref_primary_10_1016_j_drudis_2021_01_030 crossref_primary_10_2217_nnm_2019_0290 crossref_primary_10_1016_j_bioadv_2023_213357 crossref_primary_10_1007_s11307_025_02050_z crossref_primary_10_1016_j_semcancer_2019_08_030 crossref_primary_10_1007_s13204_019_01165_4 crossref_primary_10_3390_pharmaceutics13020216 crossref_primary_10_3390_pharmaceutics13101651 crossref_primary_10_1002_slct_202200759 crossref_primary_10_1007_s13346_020_00818_0 crossref_primary_10_1016_j_molliq_2022_118549 crossref_primary_10_1111_cpr_12761 crossref_primary_10_1016_j_bioadv_2022_212801 crossref_primary_10_1016_j_envres_2023_115939 crossref_primary_10_1007_s11051_020_04839_1 crossref_primary_10_1002_jlcr_3839 crossref_primary_10_1007_s13205_019_1940_0 crossref_primary_10_1016_j_semcancer_2020_02_009 crossref_primary_10_1088_2632_959X_ac7c81 crossref_primary_10_3389_fphar_2021_687399 crossref_primary_10_1016_j_addr_2022_114524 crossref_primary_10_1016_j_physb_2025_417018 crossref_primary_10_1016_j_ejphar_2020_173198 crossref_primary_10_1088_1361_6528_aba2a1 crossref_primary_10_2147_IJN_S272902 crossref_primary_10_1134_S199507801906003X crossref_primary_10_1007_s43440_023_00558_1 crossref_primary_10_3390_pharmaceutics15102448 crossref_primary_10_1016_j_apmt_2020_100722 crossref_primary_10_1016_j_inoche_2023_110858 crossref_primary_10_1016_j_jconrel_2019_01_022 crossref_primary_10_1088_1361_6528_abbfd5 crossref_primary_10_3390_nano10050995 crossref_primary_10_1016_j_biotechadv_2021_107769 crossref_primary_10_3390_pharmaceutics13040513 crossref_primary_10_1016_j_ccr_2025_217077 crossref_primary_10_3389_fbioe_2019_00197 crossref_primary_10_1039_D2RA00566B crossref_primary_10_1515_bams_2021_0136 crossref_primary_10_1016_j_tips_2020_08_003 crossref_primary_10_1016_j_ijpharm_2019_118583 crossref_primary_10_1016_j_jbiotec_2019_09_015 crossref_primary_10_1002_smll_202002733 crossref_primary_10_1080_17435390_2022_2090025 crossref_primary_10_1016_j_aca_2018_10_027 crossref_primary_10_1007_s00339_021_04706_3 crossref_primary_10_1016_j_tibtech_2019_02_005 crossref_primary_10_1177_1091581820927646 crossref_primary_10_3390_nano12183166 crossref_primary_10_2217_nnm_2018_0170 crossref_primary_10_1016_j_jfutfo_2023_05_004 crossref_primary_10_1016_j_nano_2019_102083 crossref_primary_10_1002_adtp_201900153 crossref_primary_10_3389_fphar_2018_00421 crossref_primary_10_3390_ijms22063121 crossref_primary_10_1016_j_colsurfa_2021_127298 crossref_primary_10_1016_j_jconrel_2018_07_024 crossref_primary_10_1002_advs_202300878 crossref_primary_10_1088_1748_605X_ad1baf crossref_primary_10_3390_biomedicines9010074 crossref_primary_10_3390_pharmaceutics13020261 crossref_primary_10_1002_anbr_202100029 crossref_primary_10_1016_j_addr_2018_09_004 crossref_primary_10_3390_ma13030513 crossref_primary_10_1016_j_tips_2022_08_006 crossref_primary_10_3390_cancers12061657 crossref_primary_10_1016_j_addr_2020_05_005 crossref_primary_10_3390_ma16031034 crossref_primary_10_1002_med_21509 crossref_primary_10_1186_s11671_019_3021_z crossref_primary_10_1134_S1560090420050073 crossref_primary_10_3390_jnt4010001 crossref_primary_10_1016_j_actbio_2018_11_043 crossref_primary_10_3390_polym14061188 crossref_primary_10_1016_j_jscs_2018_09_001 crossref_primary_10_1038_s41429_025_00856_1 crossref_primary_10_3390_gels9050421 crossref_primary_10_1016_j_cej_2021_133076 crossref_primary_10_1021_acsami_5c07979 crossref_primary_10_26599_NBE_2023_9290024 crossref_primary_10_1016_j_bioadv_2023_213279 crossref_primary_10_1038_s41598_019_48292_0 crossref_primary_10_3390_pharmaceutics15020433 crossref_primary_10_1007_s00289_025_06015_8 crossref_primary_10_26599_NBE_2024_9290048 crossref_primary_10_1007_s12033_024_01086_w crossref_primary_10_1007_s12032_022_01713_z crossref_primary_10_15407_biotech12_06_012 crossref_primary_10_1016_j_jddst_2022_103280 crossref_primary_10_1016_j_mtchem_2020_100381 crossref_primary_10_1016_j_ejmech_2020_112483 crossref_primary_10_1016_j_jphotobiol_2019_111736 crossref_primary_10_1016_j_optlastec_2025_112705 crossref_primary_10_3390_ijms20010217 crossref_primary_10_1002_bab_2034 crossref_primary_10_1016_j_taap_2018_08_005 crossref_primary_10_2174_0113816128265544231102065515 crossref_primary_10_3390_nano11113132 crossref_primary_10_1002_adhm_202001378 crossref_primary_10_2174_1381612827666210525154131 crossref_primary_10_1134_S0036023621100107 crossref_primary_10_1016_j_bioactmat_2020_12_010 crossref_primary_10_1016_j_biopha_2025_118399 crossref_primary_10_1007_s10103_018_2608_4 crossref_primary_10_1016_j_jcis_2025_137977 crossref_primary_10_1039_C8NR08296K crossref_primary_10_1016_j_colsurfa_2021_126654 crossref_primary_10_3390_cancers12102893 crossref_primary_10_2174_1381612826666200701151403 crossref_primary_10_3390_coatings10080717 crossref_primary_10_3390_biom11050633 crossref_primary_10_1016_j_drudis_2024_103892 crossref_primary_10_1039_D2EN00734G crossref_primary_10_1134_S0018143923090151 crossref_primary_10_1088_1361_6528_ab5d83 crossref_primary_10_1016_j_jddst_2018_06_009 crossref_primary_10_1016_j_ejpb_2019_02_013 crossref_primary_10_3390_nano11010201 crossref_primary_10_1016_j_nano_2024_102754 crossref_primary_10_1186_s12645_023_00174_x crossref_primary_10_3390_magnetochemistry9030059 crossref_primary_10_1016_j_jclepro_2022_131032
ContentType	Journal Article
Copyright	COPYRIGHT 2017 Dove Medical Press Limited 2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Guo et al. This work is published and licensed by Dove Medical Press Limited 2017
Copyright_xml	– notice: COPYRIGHT 2017 Dove Medical Press Limited – notice: 2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Guo et al. This work is published and licensed by Dove Medical Press Limited 2017
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM
DOI	10.2147/IJN.S140772
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Engineering
EISSN	1178-2013
EndPage	6152
ExternalDocumentID	oai_doaj_org_article_84718713ac72419c8a1debe84701a775 PMC5574664 A532303213 28883725 10_2147_IJN_S140772
Genre	Journal Article Review
GeographicLocations	Ireland China
GeographicLocations_xml	– name: Ireland – name: China
GroupedDBID	--- 0YH 29J 2WC 53G 5GY 5VS 7X7 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AEGXH AENEX AFFHD AFKRA AIAGR ALMA_UNASSIGNED_HOLDINGS AOIJS AQTUD AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 DIK DU5 DWQXO E3Z EBD EBS EJD EMOBN F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR ITC KQ8 M2O M48 MM. O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM SJN SV3 TDBHL TR2 UKHRP VDV ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM
ID	FETCH-LOGICAL-c608t-38f0a14007bba6060ae6181be296d77bd6dd1eb9c0f1540b4cc7b7a52db8569d3
IEDL.DBID	BENPR
ISICitedReferencesCount	194
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000408096000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1178-2013 1176-9114
IngestDate	Mon Nov 10 04:36:11 EST 2025 Tue Nov 04 01:58:53 EST 2025 Sun Nov 09 05:03:08 EST 2025 Tue Oct 07 06:51:53 EDT 2025 Tue Nov 11 10:35:13 EST 2025 Tue Nov 04 18:06:15 EST 2025 Mon Jul 21 05:49:20 EDT 2025 Tue Nov 18 22:36:43 EST 2025 Sat Nov 29 06:01:34 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	cancer bioimaging multifunctional gold nanoparticles cancer photothermal and photodynamic therapy
Language	English
License	http://creativecommons.org/licenses/by-nc/3.0 The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c608t-38f0a14007bba6060ae6181be296d77bd6dd1eb9c0f1540b4cc7b7a52db8569d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
OpenAccessLink	https://www.proquest.com/docview/2239672339?pq-origsite=%requestingapplication%
PMID	28883725
PQID	2239672339
PQPubID	3933144
PageCount	22
ParticipantIDs	doaj_primary_oai_doaj_org_article_84718713ac72419c8a1debe84701a775 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5574664 proquest_miscellaneous_1937518841 proquest_journals_2239672339 gale_infotracmisc_A532303213 gale_infotracacademiconefile_A532303213 pubmed_primary_28883725 crossref_citationtrail_10_2147_IJN_S140772 crossref_primary_10_2147_IJN_S140772
PublicationCentury	2000
PublicationDate	2017-01-01
PublicationDateYYYYMMDD	2017-01-01
PublicationDate_xml	– month: 01 year: 2017 text: 2017-01-01 day: 01
PublicationDecade	2010
PublicationPlace	New Zealand
PublicationPlace_xml	– name: New Zealand – name: Macclesfield
PublicationTitle	International journal of nanomedicine
PublicationTitleAlternate	Int J Nanomedicine
PublicationYear	2017
Publisher	Dove Medical Press Limited Taylor & Francis Ltd Dove Medical Press
Publisher_xml	– name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Medical Press
SSID	ssj0057869
Score	2.5785644
SecondaryResourceType	review_article
Snippet	Development of multifunctional nanomaterials, one of the most interesting and advanced research areas in the field of nanotechnology, is anticipated to... Jianfeng Guo,1 Kamil Rahme,2-4 Yan He,1 Lin-Lin Li,5 Justin D Holmes,3,4 Caitriona M O'Driscoll6 1School of Pharmaceutical Sciences, Jilin University,...
SourceID	doaj pubmedcentral proquest gale pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	6131
SubjectTerms	Acids Biomedical materials cancer bioimaging Cancer diagnosis cancer photothermal and photodynamic therapy Cancer therapies Drug delivery systems Gold Gold - chemistry Humans Metal Nanoparticles - administration & dosage Metal Nanoparticles - chemistry Multifunctional gold nanoparticles Nanomaterials Nanoparticles Neoplasms - diagnosis Neoplasms - therapy Particle size Photochemotherapy Photochemotherapy - methods Photodynamic therapy Phototherapy - methods Polyethylene glycol Quantum dots Review Seeds Silver Surface Plasmon Resonance Surfactants Theranostic Nanomedicine - methods University colleges
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yeNCD-LbdVSIsCEKz3Ul3HhdhFdcHMgg-2FvIq9mRJS0zs_v7rUp6hmkUvHjoS5ImSVUlVV938hUhx_hHUFjtasXboe5awClOBVHLqIIHfSuRmZh-fJaLhTo_11_2Un3hmbBCD1wEd5J3T0BS1ktwNtor2wboGIqb1kqZ2Ush6tmCqbIHgxnmZHYt9g0ujpebeZiT52T5E7QLsEJKNvNFmbL_z415zzPNT03uuaGzu-TOFD_S0zLue-RGTPfJ7T1WwQfk9fvxMtBkE-Dh6dgbxW8WgMJjohDw0UIkQseBelT6iuZbWGnMnM0Pyfezd9_efqinNAm1F43a1FwNjW0xv7lzFvBIY6MAv-0i0yJI6YIIoY1O-2aAeKlxnffSSduz4FQvdOCPyEEaU3xCqBicC130DJ4uNtpq3kkfOtbw3ivlK_JqKzDjJw5xTGVxaQBLoHTNx08L87VItyLHu8a_CnXG35u9QcnvmiDfdS4AKzCTmMy_rKAiL1FvBlclDMjb6XIBTAv5rcxpzwFrcdbyihzNWsJq8vPqrebNtJrXBkIoDTbLua7Ii101vokn1FIcr9YGAmH8g6W6tiKPi6HspsSUUlwyGKWcmdBszvOatLzIXN99LzEBwNP_IaRDcothUJI_IB2Rg83qKj4jN_31ZrlePc8L6DcOYhyk priority: 102 providerName: Directory of Open Access Journals
Title	Gold nanoparticles enlighten the future of cancer theranostics
URI	https://www.ncbi.nlm.nih.gov/pubmed/28883725 https://www.proquest.com/docview/2239672339 https://www.proquest.com/docview/1937518841 https://pubmed.ncbi.nlm.nih.gov/PMC5574664 https://doaj.org/article/84718713ac72419c8a1debe84701a775
Volume	12
WOSCitedRecordID	wos000408096000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: PIMPY dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: M2O dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1178-2013 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057869 issn: 1178-2013 databaseCode: 0YH dateStart: 20060901 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLQc48H4EyipIlZCQQpM4iZ0LqEUtFNFlxUvbk-VXoFKVlN0tv58Zx7tsBOLCIT7YjmR7xvOy_Q3ALp0IVqrWiWBZkxQZ-ila2CrhTliD9BaVR2L6-p5PJmI2q6ch4LYI1ypXMtELatsZipHvoRqr8T_G6lcXPxLKGkWnqyGFxhZsE1JZMYLtg8PJ9ONKFiM7-qR2WcYr2tZF_0KPcvPsHb-bvPiE7gXn-UAneej-PwX0hoYa3p7cUEdHN_93IrfgRjBE4_2ec27DFdfegesb8IR34eWb7tzGrWrRsQ7352IKfqA779oYLce4RySJuyY2xD3z2D_najsP_nwPvhwdfn79Ngn5FhJTpWKZMNGkKqNE6VordGxS5So0ALTL68pyrm1lbeZ0bdIGDa9UF8ZwzVWZWy3KqrbsPozarnUPIa4arW3hTI5f4dJa1azgxhZ5ykojhIng-WrFpQlg5JQT41yiU0LkkUgeGcgTwe6680WPwfH3bgdEunUXAs72Fd38mwzLJL0yRsdcGY62S22EyizyMVanmeK8jOAZEV7S9sYBGRVeKeC0CChL7pcMnTaWZyyCnUFP3JZm2LwivwxiYSF_0z6Cp-tm-pOuurWuu1xItKjpKEwUWQQPek5bTykXQjCe4yj5gAcHcx62tGffPWh4WXLKJPDo38N6DNdyslt8jGkHRsv5pXsCV83P5dliPoYtPuO-FOOw08Y-iIHlSf4B66bHJ9PTX_r2MgI
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKQQIO7EugQJCKkJBCYzuJnQOgspQOHUZIFDQ3423aSlUyzExB_Cl-I-85yTARiFsPHHKJ7cTL9zb7-T1CNvFEsNClSSSnkySjYKcY6YpEeOksrLcsQiSmz0MxGsnxuPywRn52d2HQrbLjiYFRu9riHvkWiLES2nFevph-TTBrFJ6udik0Gljs-R_fwWSbPxu8hvV9xNjOm_1Xu0mbVSCxRSoXCZeTVFNMB26MBvU91b4AMWc8KwsnhHGFc9Sb0qYTUC9Sk1krjNA5c0bmRek4fPcMOQt8XKALmRgvDTwAf0ihR6kokIlkzX1AzAS0NXg3evoR_ioE60nAkCjgT3GwIg_7vporwm_n8v82bVfIpVbNjrcburhK1nx1jVxcCb54nTx_Wx-7uNJVPe28A2Pc2jk4BDMiBr04buKtxPUktkgbszhcVqvqENr6Bvl0KgO4SdaruvK3SVxMjHGZtwyezKelLnkmrMtYynMrpY3Ik26FlW1DrWPGj2MFJhfCQQEcVAuHiGwuK0-bCCN_r_YSobKsgmHBw4t6dqDaaVJB1RCUaytAMyut1NQBlcLrlGoh8og8RqApZF7QIavbOxgwLAwDprZzDiYpZ5RHZKNXE5iO7Rd3cFMt05ur31iLyMNlMbZER77K1ydzBfYCHvTJjEbkVoPs5ZCYlJILBr0UPcz3xtwvqY4OQ0j0PBeYJ-HOv7v1gJzf3X8_VMPBaO8uucBQQwu7aRtkfTE78ffIOfttcTSf3Q90HZMvp00RvwDHlojH
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKixAc2JdAgSAVISGFie0kdg6AWtrC0Go0ooB6M97SVqqSYWYK4q_x63gvyzARiFsPHHKJ7cTL9zb7-T1CNvBEMNO5iSSnRZRQsFOMdFkkvHQW1ltmdSSmz_tiNJKHh_l4hfzs7sKgW2XHE2tG7SqLe-QDEGM5tOM8HxStW8R4e_f15GuEGaTwpLVLp9FAZM__-A7m2-zlcBvW-iljuzsf37yL2gwDkc1iOY-4LGJNMTW4MRpU-Vj7DESe8SzPnBDGZc5Rb3IbF6BqxCaxVhihU-aMTLPccfjuBbImQMkA6lrb2hmNP3RyAEihTqhHqciQpSTN7UDMCzQYvh-9OID_CsF68rBOG_CncFiSjn3PzSVRuHvtf57E6-Rqq4CHmw3F3CArvrxJriyFZbxFXr2tTl1Y6rKadH6DIW76HB2DgRGCxhw2kVjCqggtUs00rK-xlVUd9Po2-XQuA7hDVsuq9PdImBXGuMRbBk_i41znPBHWJSzmqZXSBuR5t9rKtkHYMRfIqQJjDKGhABqqhUZANhaVJ03skb9X20LYLKpgwPD6RTU9Uu00qVoJEZRrK0Bny63U1AH9wuuYaiHSgDxD0Clka9Ahq9vbGTAsDBCmNlMOxipnlAdkvVcT2JHtF3fQUy07nKnfuAvIk0UxtkQXv9JXZzMFlgQeAcqEBuRug_LFkJiUkgsGvRQ9_PfG3C8pT47rYOlpKjCDwv1_d-sxuQSEoPaHo70H5DJD1a3eZlsnq_PpmX9ILtpv85PZ9FFL5CH5ct4k8QsFx5Lo
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gold+nanoparticles+enlighten+the+future+of+cancer+theranostics&rft.jtitle=International+journal+of+nanomedicine&rft.au=Guo%2C+Jianfeng&rft.au=Rahme%2C+Kamil&rft.au=He%2C+Yan&rft.au=Li%2C+Lin-Lin&rft.date=2017-01-01&rft.issn=1178-2013&rft.eissn=1178-2013&rft.volume=12&rft.spage=6131&rft.epage=6152&rft_id=info:doi/10.2147%2FIJN.S140772&rft.externalDBID=n%2Fa&rft.externalDocID=10_2147_IJN_S140772
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2013&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2013&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2013&client=summon